Lopinavir/Ritonavir Ranbaxy

Medicinal product

(Invented) name

Lopinavir/Ritonavir Ranbaxy

Active substance (s)

Lopinaviras/Ritonaviras

Strength

100 mg/25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR10, Lopinavir and ritonavir

Marketing authorisation holder

Ranbaxy (UK) Limited, Jungtinė Karalystė

Date of authorisation

2014-02-11

Date of renewal

Documents

3510_1_6 Lopinavir_Ritonavir Ranbaxy 170224.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

FR/H/0545/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Lopinaviras	100 mg
Ritonaviras	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
52924	66862	1066862	lizdinė plokštelė	N60		Receptinis	LT/1/14/3510/001	Netiekiama	-	-	No	-	-
52923	66861	1066861	buteliukas	N60		Receptinis	LT/1/14/3510/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-04-05	Išregistruotas
2014-02-11	Registruotas